Up­dat­ed: Cit­ing ef­fi­ca­cy, GSK halts UTI an­tibi­ot­ic tri­al ear­ly, plans to file for FDA ap­proval next year

GSK an­nounced this morn­ing that it is wrap­ping up two large clin­i­cal tri­als on a new an­tibi­ot­ic for un­com­pli­cat­ed uri­nary tract in­fec­tions ear­ly, set­ting it …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER